Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Country / region: Australia Clear all

147 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20063
20071
20081
20093
20108
20112
20121
20135
20147
20158
20169
201713
201815
201911
202010
20219
20228
20237
20248
202510
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Terminated34
Recruiting21
Active, not recruiting20
Unknown status9
No longer available1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie14
Novartis Pharmaceuticals10
Institut de Recherches Internationales Servier6
Celgene5
Janssen Research & Development, LLC5
Amgen4
Children's Oncology Group4
Daiichi Sankyo4
Hoffmann-La Roche4
Stichting Hemato-Oncologie voor Volwassenen Nederland4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute147
Myelodysplastic Syndromes34
Leukemia26
Recurrence17
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Leukemia, Myelomonocytic, Chronic12
Neoplasms12
Lymphoma, Non-Hodgkin11
Multiple Myeloma10
Leukemia, Lymphocytic, Chronic, B-Cell7

Trials

Showing 26 to 50 of 147. Each trial links to its page on Pharma Observatory.

47 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.